Serotonin 5-HT7 receptors mediate relaxation of porcine pial veins

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 278, Issue 3 47-3, 2000, Pages

  Ishine, Takaaki ^a   Bouchelet, Isabelle ^b   Hamel, Edith ^b   Lee, Tony J F ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

5 HT7 messenger ribonucleic acid; In vitro tissue bath; Pig; Reverse transcription polymerase chain reaction; Vasodilation

Indexed keywords

5 CARBAMOYLTRYPTAMINE; CLOZAPINE; N (2 HYDROXYCYCLOPENTYL) 1 ISOPROPYL 6 METHYLERGOLINE 8 CARBOXAMIDE; PIMOZIDE; SEROTONIN; SEROTONIN 7 RECEPTOR;

ANIMAL TISSUE; ARTICLE; BRAIN VEIN; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWINE; VEIN DILATATION;

EID: 0034022942     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2000.278.3.h907     Document Type: Article

References (47)

1. Adham, N., J. M. Zgombick, J. Bard, and T. A. Branchek. Functional characterization of the recombinant human 5-hydroxytryptamine7(a) receptor isoform coupled to adenylate cyclase stimulation. J. Pharmacol. Exp. Ther. 287: 508-514, 1998.
2. Amlaiky, N., S. Ramboz, U. Boschert, J. L. Plassat, and R. Hen. Isolation of a mouse "5HT1E-like" serotonin receptor expressed predominantly in hippocampus. J. Biol. Chem. 267: 19761-19764, 1992.
3. Arunlakshana, O., and H. O. Schild. Some quantitative uses of drugs antagonists. Br. J. Pharmacol. 14: 48-58, 1959.
4. Bard, J. A., J. Zgombick, N. Adham, P. Vaysse, T. A. Branchek, and R. L. Weinshank. Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. J. Biol. Chem. 5: 23422-23426, 1993.
5. Carter, D., B. Huang, M. Champney, and R. M. Eglen. Characterization of a postjunctional receptor mediating relaxation of guinea-pig isolated ileum. Ear. J. Pharmacol. 280: 243-250, 1995.
6. Chomczynski, P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15: 532-535, 1993.
7. 4 receptor. J. Pharmacol. Exp. Ther. 252: 1378-1386, 1990.
8. Cushing, D. J., J. M. Zgombick, D. L. Nelson, and M. L. Cohen. Ly215840, a high affinity 5-HT7 receptor ligand, blocks serotonin-induced relaxation in canine coronary artery. J. Pharmacol. Exp. Ther. 277: 1560-1566, 1996.
9. Deckert, V., D. Pruneau, and J. L. Elghozi. Mediation by 5-HT1D receptors of 5-hydroxytryptamine-induced contractions of rabbit middle and posterior cerebral arteries. Br. J. Pharmacol. 112: 939-945, 1994.
10. Deliganis, A. V., and S. J. Peroutka. 5-Hydroxtryptamine1D receptor agonism predicts antimigraine efficacy. Headache 31: 228-231, 1991.
11. De, Vries, P., C. M. Villalon, J. P. Heiligers, and P. R. Saxena. Nature of 5-HT1-like receptors mediating depressor responses in vagosympathectomized rats: close resemblance to the cloned 5-ht7 receptors. Naunyn Schmiedebergs Arch. Pharmacol. 350: 90-99, 1997.
12. Dyer, S. M., I. S. de la Lande, D. B. Frewin, and R. J. Head. 5-Hydroxytryptamine-induced contraction of the marmoset aorta is mediated by a 5-HT1-like receptor. Clin. Exp. Pharmacol. Physiol. 25: 246-251, 1998.
13. Eglen, R. M., J. R. Jasper, D. J. Chang, and G. R. Martin. The 5-HT7 receptor: orphan found. Trends Pharmacol. Sci. 18: 104-107, 1997.
14. Fleming, W. W., D. P. Westfall, I. S. De la Lande, and L. B. Jellett. Log-normal distribution of equiefective doses of norepinephrine and acetylcholine in several tissues. J. Pharmacol. Exp. Ther. 181: 339-345, 1972.
15. Hamel, E., E. Fan, D. Linville, V. Ting, J. G. Villemure, and L. S. Chia. Expression of mRNA for the serotonin 5-hydroxytryptamine 1D beta receptor subtype in human and bovine cerebral arteries. Mol. Pharmacol. 44: 242-246, 1993.
16. Harder, D. R. Pressure-dependent depolarization in cat middle cerebral artery. Circ. Res. 55: 197-202, 1984.
17. Humphrey, P. P., W. Feniuk, M. J. Perren, H. E. Connor, A. W. Oxford, L. H. Coates, and D. Butina. GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein. Br. J. Pharmacol. 94: 1123-1132, 1988.
18. Ishine, T., and T. J-F. Lee. Norepinephrine attenuates serotonin inhibition of pial venous tone. Eur. J. Pharmacol. 313: 97-102, 1996.
19. Kitazawa, T., O. Kubo, M. Satoh, and T. Taneike. Involvement of 5-hydroxytryptamine7 receptors in inhibition of porcine myometrial contractility by 5-hydroxytryptamine. Br. J. Pharmacol. 123: 173-182, 1998.
20. Lee, T. J-F. Recent studies on serotonin-containing fibers in cerebral circulation. In: Neurotransmission and Cerebrovascular Function, edited by J. Seylaz and R. Sercombe. Elsevier, 1989, p. 133-149.
21. 1-like receptors mediate pial venous relaxation. In: Neurotransmission and Cerebrovascular Function, edited by J. Seylaz and MacKenzie. Elsevier, 1989, p. 233-236.
22. Lee, T. J.-F., M. Ueno, N. Sunagane, and M. H. Sun. Serotonin relaxes porcine pial veins. Am. J. Physiol. Heart Circ. Physiol. 266: H1000-H1006, 1994.
23. Leung, E., L. K. Walsh, M. T. Pulido-Rio, and R. M. Eglen. Characterization of putative 5-HT7 receptors mediating direct relaxation in cynomolgus monkey isolated jugular veins. Br. J. Pharmacol. 117: 926-930, 1996.
24. MacLennan, S. J., D. Cambridge, M. V. Whiting, C. Marston, and G. R. Martin. Cranial vascular effects of zolmitriptan, a centrally active 5-HT1B/1D receptor partial agonist for the acute treatment of migraine. Eur. J. Pharmacol. 36: 191-197, 1998.
25. Martin, G. R., and P. P. Humphrey. Receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature. Neuropharmacology 33: 261-273, 1994.
26. Martin, G. R., and R. Wilson. Operational characteristics of a 5-HT receptor mediating direct vascular relaxation: identity with the 5-HT7 receptor? (Abstract). Br. J. Pharmacol. 114: 383p, 1995.
27. McAllister, G., A. Charlesworth, C. Snodin, M. S. Beer, A. J. Noble, D. N. Middlemiss, L. L. Iversen, and P. Whiting. Molecular cloning of a serotonin receptor from human brain (5HT1E): a fifth 5HT1-like subtype. Proc. Natl. Acad. Sci. USA 89: 5517-21, 1992.
28. Middlemiss, D. N., and J. R. Fozard. 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site. Eur. J. Pharmacol. 90: 151-153, 1983.
29. Miranda, F. J., G. Torregrosa, J. B. Salom, J. A. Alabadi, T. Jover, M. D. Barbera, and E. Alborch. Characterization of 5-hydroxytryptamine receptors in goat cerebral arteries. Gen. Pharmacol. 26: 1267-1272, 1995.
30. Morecroft, I., and M. R. MacLean. 5-Hydroxytryptamine receptors mediating vasoconstriction and vasodilation in perinatal and adult rabbit small pulmonary arteries. Br. J. Pharmacol. 125: 69-78, 1998.
31. Peroutka, S. J., A. W. Schmidt, A. J. Sleight, and M. A. Harrington. Serotonin receptor "families" in the central nervous system: an overview. Ann. NY Acad. Sci. 600: 104-112, 1990.
32. Petty, M. A., J. Elands, M. P. Johnson, M. D. Linnik, E. Hamel, M. A. Moskowitz, W. S. Lee, D. R. McCarty, M. Hibert, and B. M. Baron. The selectivity of MDL 74,721 in models of neurogenic versus vascular components of migraine. Eur. J. Pharmacol. 336: 127-136, 1997.
33. Plassat, J. L., N. Amlaiky, and R. Hen. Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. Mol. Pharmacol. 44: 229-236, 1993.
34. Ruat, M., E. Traiffort, J. M.Arrang, J. Tardivel-Lacombe, J. Diaz, R. Leurs, and J. C. Schwartz. A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation. Biochem. Biophys. Res. Commun. 193: 268-276, 1993.
35. Ruat, M., E. Traiffort, R. Leurs, J. Tardivel-Lacombe, J. Diaz, J. M. Arrang, and J. C. Schwartz. Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc. Natl. Acad. Sci. USA 90: 8547-8551, 1993b.
36. Schoeffter, P., and D. Hoyer. 5-Hydroxytryptamine 5-HT1B and 5-HT1D receptors mediating inhibition of adenylate cyclase activity. Pharmacological comparison with special reference to the effects of yohimbine, rauwolscine and some beta-adrenoceptor antagonists. Naunyn Schmiedebergs Arch. Pharmacol. 340: 285-292, 1989.
37. Schoeffter, P., C. Ullmer, I. Bobirnac, G. Gabbiani, and H. Lubbert. Functional, endogenously expressed 5-hydroxytryptamine 5ht-7 receptors in human vascular smooth muscle cells. Br. J. Pharmacol. 117: 993-994, 1996.
38. Sebben, M., H. Ansanay, J. Bockaert, and A. Dumuis. 5-HT6 receptors positively coupled to adenylyl cyclase in striatal neurones in culture. Neuroreport 5: 2553-2557, 1994.
39. Shen, Y., F. J. Monsma, Jr., M. A. Metcalf, P. A. Jose, M. W. Hamblin, and D. R. Sibley. Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J. Biol. Chem. 268: 18200-18204, 1993.
40. Shirasaki, Y., C. Su, P. Kolm, T. J-F. Lee, W. H. Cline, Jr., and G. A. Nickols. Endothelial modulation of vascular relaxation to nitrovasodilators in aging and hypertension. J. Pharmacol. Exp. Ther. 239: 861-866, 1986.
41. Sumner, M. J., and P. P. Humphrey. Sumatriptan (GR43175) inhibits cyclic-AMP accumulation in dog isolated saphenous vein. Br. J. Pharmacol. 99: 219-220, 1990.
42. Terron, J. A. The relaxant 5-HT receptor in the dog coronary artery smooth muscle: pharmacological resemblance to the cloned 5-ht7 receptor subtype. Br. J. Pharmacol. 118: 1421-1428, 1996.
43. Terron, J. A. Role of 5-ht7 receptors in the long-lasting hypertensive response induced by 5-hydroxytrypyamine in the rat. Br. J. Pharmacol. 121: 563-571, 1997.
44. 1-like receptor subtype mediates cAMP synthesis in the porcine pial vein. Am. J. Physiol. Heart Circ. Physiol. 268: H1383-H1389, 1995.
45. Ullmer, C., K. Schmuck, H. O. Kalkman, and H. Lubbert. Expression of serotonin receptor mRNAs in blood vessels. FEBS Lett. 370: 215-221, 1995.
46. Villalon, C. M., D. Centurion, M. Lujan-Estrada, J. A. Terron, and A. Sanchez-Lopez. Mediation of 5-HT-induced external carotid vasodilation in GR-127935-pretreated vagosympathectomized dogs by the putative 5-HT7 receptors. Br. J. Pharmacol. 120: 1319-1327, 1997.
47. Zgombick, J. M., L. A. Borden, T. L. Cochran, S. A. Kucharewicz, R. L. Weinshank, and T. A. Branchek. Dual coupling of cloned human 5-hydroxytryptamine1D alpha and 5-hydroxytryptamine1D beta receptors stably expressed in murine fibroblasts: inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein(s). Mol. Pharmacol. 44: 575-582, 1993.